Key result
Dynamic regulation of macrophage polarization by Sirpα, specifically downregulation at early stages and upregulation at late stages, promoted angiogenesis and alleviated ischemic diseases in mouse models.
Why the study?
The role and underlying mechanisms of pro-inflammatory and anti-inflammatory polarized macrophages in modulating ischemic diseases remain incompletely understood.
Does dynamic regulation of Sirpα in macrophages improve angiogenesis and alleviate ischemic diseases in mouse models?
Does dynamic regulation of Sirpα in macrophages improve angiogenesis and alleviate ischemic diseases in mouse models?
Dynamic time-dependent regulation of Sirpα in macrophages plays a critical role in promoting angiogenesis and alleviating ischemic diseases in preclinical models.
Sirpα modulation of polarized macrophages in mouse ischemia models is hypothesis-generating; leaves open clinical translation to human ischemic disease.
BACKGROUND: macrophage-targeting therapy of ischemic disease has made progress in clinic trial. However, the role and underlying mechanism of pro-inflammatory or anti-inflammatory polarized macrophages in modulating ischemic diseases remain incompletely understood. RESULTS: here we examine the effect of pro-inflammatory (LPS) and anti-inflammatory (IL-4) macrophage on ischemic diseases in a mouse ischemic hindlimb and heart model, and identify that signal regulatory protein α (Sirpα) modulates macrophage polarization induced angiogenesis via promoting phagocytosis or activating HIF1α nucleus relocation in macrophages, respectively. More importantly, the therapeutic effect of polarized macrophages is controlled by Sirpα in a time-dependent manner. Downregulation of macrophage Sirpα at the early-stage or upregulation of macrophage Sirpα at the late-stage of ischemic disease enhances the therapeutic effect. In contrast, increasing Sirpα at the early-stage or decreasing it at the late-stage leads to failure of inducing ischemic disease resilience. Mechanistically, we find that signal transducer and activator of transcription 3 and 6 (Stat3 and Stat6) mediate downregulation (pro-inflammatory polarization) or upregulation (anti-inflammatory polarization) of Sirpα, respectively. CONCLUSION: Our results reveal that dynamic regulation of macrophage by Sirpα plays a critical role in alleviating ischemic diseases.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied Ischemic diseases (hindlimb ischemia and myocardial infarction). Pro-inflammatory (LPS) or anti-inflammatory (IL-4) macrophage polarization vs. PBS was evaluated on Blood perfusion restoration and angiogenesis. Dynamic regulation of macrophage polarization by Sirpα, specifically downregulation at early stages and upregulation at late stages, promoted angiogenesis and alleviated ischemic diseases in mouse models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: